The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Cassella James V since year 2005.
The trader's CIK number is 1353528.
At the time of this reporting, Cassella James V is the Chief Development Officer of Concert Pharmaceuticals, Inc. .
(stock ticker symbol CNCE).
See this page for all insider trading activities at Concert Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-04-17||CNCE||Concert Pharmaceuticals, Inc.||Sale||10,582||20.18||213,513|
|2012-12-26||ALXA||Alexza Pharmaceuticals Inc.||Sale||4,558||4.90||22,315|
|2012-08-27||ALXA||Alexza Pharmaceuticals Inc.||Sale||10,000||4.14||41,360|
|2012-06-06||ALXA||Alexza Pharmaceuticals Inc.||Sale||46,222||.34||15,623|
|2009-12-18||ALXA||Alexza Pharmaceuticals Inc.||Sale||12,408||2.13||26,391|
|2009-12-17||ALXA||Alexza Pharmaceuticals Inc.||Sale||4,284||2.20||9,429|
|2009-12-16||ALXA||Alexza Pharmaceuticals Inc.||Sale||7,732||2.41||18,610|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cassella James V (Chief Development Officer of Concert Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.